Related Experiment Video
Updated: Jul 7, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Primary early correction of tetralogy of Fallot irrespective of age
Andrea Kantorova1, Kai Zbieranek, Henning Sauer
1Slovak Pediatric Heart Centre, Bratislava, Slovakia.
Insights
Primary repair of tetralogy of Fallot in infants younger than 6 months is safe and effective. This approach offers excellent midterm outcomes with acceptable morbidity and reintervention rates, regardless of age at surgery.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Surgery
- Neonatal Intensive Care
Background:
- The optimal surgical timing for tetralogy of Fallot (TOF) remains debated, with strategies ranging from early primary repair to initial palliation.
- Early repair policies aim to avoid staged palliation and its associated risks.
Purpose of the Study:
- To evaluate the midterm outcomes of primary early correction for tetralogy of Fallot in infants under 6 months of age.
- To compare outcomes between infants operated on before and after 3 months of age.
Main Methods:
- A cohort of 61 consecutive infants (<6 months) underwent primary TOF repair between 1996 and 2005.
- Patients were stratified into two groups: <3 months and 3-6 months at the time of surgery.
- Midterm outcomes including survival, reoperation rates, and postoperative complications were analyzed.
Main Results:
- Actuarial survival was excellent at 98.4% at 1 year, 96.7% at 5 years, and 96.7% at 10 years, with a median follow-up of 4.5 years.
- No significant differences in survival, bypass time, ventilation duration, or hospital stay were observed between the age groups.
- Freedom from reoperation was high (98.2% at 1 year, 92.2% at 5 years, 83% at 10 years) with no significant difference between groups.
Conclusions:
- Primary repair of tetralogy of Fallot in infants under 6 months is a safe and effective strategy, yielding excellent midterm results.
- The approach is suitable for symptomatic infants regardless of age, weight, or preoperative condition.
- Long-term evaluation focusing on arrhythmias, ventricular function, and exercise performance is warranted.
Objective:
The policy of early repair of patients with tetralogy of Fallot, irrespective of age, as opposed to initial palliation with a shunt, remains controversial. The aim of our study was to analyze the midterm outcome of primary early correction of tetralogy of Fallot.
Methods:
Between 1996 and 2005, a total of 61 consecutive patients less than 6 months of age underwent primary correction of tetralogy of Fallot in two institutions. The median age at surgery was 3.3 months, and 27 patients (44%) were younger than 3 months of age, including 12 (20%) newborns. We analyzed the patients in 2 groups: those younger than 3 months of age, and those aged between 3 and 6 months.
Results:
There was one early (1.6%), and one late death. Actuarial survival was 98.4%, 96.7%, 96.7% at 1, 5, and 10 years respectively, with a median follow up of 4.5 years. There was no difference in survival, bypass time, lengths of ventilation, and hospital stay between the groups. A transjunctional patch was placed significantly more often in the patients younger than 3 months (p = 0.039), with no adverse effect on survival and morbidity during the follow-up. Freedom from reoperation was 98.2%, 92.2%, and 83% at 1, 5, and 10 years respectively, with no difference between the groups.
Conclusion:
Elective primary repair of tetralogy of Fallot in asymptomatic patients is delayed beyond 3 months of age. In symptomatic patients, primary repair of tetralogy of Fallot is performed irrespective of age, weight and preoperative state. This approach is safe, and provides an excellent midterm outcome with acceptable morbidity and rates of reintervention. The long-term benefits of this approach must be established by careful follow-up, with particular emphasis on arrhythmias, right ventricular function, and exercise performance.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation III: Medical Management
Cardiopulmonary Resuscitation I: Adult
Aortic Regurgitation IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
